Potential relationship between Hashimoto's thyroiditis and BRAFV600E mutation status in papillary thyroid cancer

Head and Neck

Volumn 38, Issue , 2016, Pages E1019-E1025

  Zeng, Rui Chao ^a   Jin, Lang Ping ^a   Chen, En Dong ^a   Dong, Si Yang ^a   Cai, Ye Feng ^a   Huang, Guan Li ^a   Li, Quan ^a   Jin, Chun ^a   Zhang, Xiao Hua ^a   Wang, Ou Chen ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

aggressive factors; BRAFV600E mutation; Hashimoto' s thyroiditis; protective factor; thyroid cancer

Indexed keywords

B RAF KINASE; B RAF V600E KINASE; UNCLASSIFIED DRUG; BRAF PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER INCIDENCE; FEMALE; GENE MUTATION; HASHIMOTO DISEASE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; THYROID CARCINOMA; THYROIDECTOMY; COMPLICATION; CROSS-SECTIONAL STUDY; GENETICS; MUTATION; NECK DISSECTION; RETROSPECTIVE STUDY; THYROID TUMOR;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HASHIMOTO DISEASE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; NECK DISSECTION; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84937131226     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.24149     Document Type: Article

References (50)

1. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R,. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013; 2013: 965212.
2. Dailey ME, Lindsay S, Skahen R,. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955; 70: 291-297.
3. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR,. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 1995; 76: 2312-2318.
4. Lee JH, Kim Y, Choi JW, Kim YS,. The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis. Eur J Endocrinol 2013; 168: 343-349.
5. Xing M,. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007; 28: 742-762.
6. Rodolico V, Cabibi D, Pizzolanti G, et al., BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid
7. Xing M, Clark D, Guan H, et al., BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 2009; 27: 2977-2982.
8. Lin KL, Wang OC, Zhang XH, Dai XX, Hu XQ, Qu JM,. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann Surg Oncol 2010; 17: 3294-3300.
9. Kashima K, Yokoyama S, Noguchi S, et al., Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 1998; 8: 197-202.
10. Kim HS, Choi YJ, Yun JS,. Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol 2010; 21: 149-153.
11. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP,. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 1999; 126: 1070-1076; discussion 1076-1077.
12. Kim SJ, Myong JP, Jee HG, et al., Combined effect of Hashimoto's thyroiditis and BRAF V600E mutation status on aggressiveness in papillary thyroid cancer. Head Neck 2014. [Epub ahead of print].
13. Marotta V, Guerra A, Zatelli MC, et al., BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present. Clin Endocrinol (Oxf) 2013; 79: 733-738.
14. Kim SK, Song KH, Lim SD, et al., Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid 2009; 19: 137-141.
15. Bozec A, Lassalle S, Hofman V, Ilie M, Santini J, Hofman P,. The thyroid gland: a crossroad in inflammation-induced carcinoma? An ongoing debate with new therapeutic potential. Curr Med Chem 2010; 17: 3449-3461.
16. Konturek A, Barczyński M, Nowak W, Wierzchowski W,. Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis. Langenbecks Arch Surg 2014; 399: 229-236.
17. Lun Y, Wu X, Xia Q, et al., Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngol Head Neck Surg 2013; 148: 396-402.
18. Kim KW, Park YJ, Kim EH, et al., Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis. Head Neck 2011; 33: 691-695.
19. Noureldine SI, Tufano RP,. Association of Hashimoto's thyroiditis and thyroid cancer. Curr Opin Oncol 2015; 27: 21-25.
20. Zhang Y, Dai J, Wu T, Yang N, Yin Z,. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. J Cancer Res Clin Oncol 2014; 140: 1021-1026.
21. Holm LE, Blomgren H, Löwhagen T,. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312: 601-604.
22. Rago T, Di Coscio G, Ugolini C, et al., Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin Endocrinol (Oxf) 2007; 67: 363-369.
23. Anil C, Goksel S, Gursoy A,. Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 2010; 20: 601-606.
24. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA,. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 2006; 91: 4295-4301.
25. Zhang L, Li H, Ji QH, et al., The clinical features of papillary thyroid cancer in Hashimoto's thyroiditis patients from an area with a high prevalence of Hashimoto's disease. BMC Cancer 2012; 12: 610.
26. Azizi G, Keller JM, Lewis M, et al., Association of Hashimoto's thyroiditis with thyroid cancer. Endocr Relat Cancer 2014; 21: 845-852.
27. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
28. Muzza M, Degl'Innocenti D, Colombo C, et al., The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 2010; 72: 702-708.
29. Takahashi M, Buma Y, Iwamoto T, Inaguma Y, Ikeda H, Hiai H,. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 1988; 3: 571-578.
30. Unger P, Ewart M, Wang BY, Gan L, Kohtz DS, Burstein DE,. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link? Hum Pathol 2003; 34: 764-769.
31. Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA,. Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J Clin Endocrinol Metab 2013; 98: 2409-2414.
32. Kwon JH, Nam ES, Shin HS, Cho SJ, Park HR, Kwon MJ,. P2X7 receptor expression in coexistence of papillary thyroid carcinoma with Hashimoto's thyroiditis. Korean J Pathol 2014; 48: 30-35.
33. Larson SD, Jackson LN, Riall TS, et al., Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 2007; 204: 764-773; discussion 773-775.
34. Anderson CE, Graham C, Herriot MM, Kamel HM, Salter DM,. CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto's thyroiditis. Histopathology 2009; 55: 683-686.
35. Kim TH, Park YJ, Lim JA, et al., The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis. Cancer 2012; 118: 1764-1773.
36. Xing M, Westra WH, Tufano RP, et al., BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 2005; 90: 6373-6379.
37. Xing M, Alzahrani AS, Carson KA, et al., Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 2013; 309: 1493-1501.
38. Xing M, Alzahrani AS, Carson KA, et al., Association between BRAF V600E mutation and recurrence of papillary thyroid cancer. J Clin Oncol 2015; 33: 42-50.
39. Guan H, Ji M, Bao R, et al., Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab 2009; 94: 1612-1617.
40. Frasca F, Nucera C, Pellegriti G, et al., BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer 2008; 15: 191-205.
41. Mathur A, Moses W, Rahbari R, et al., Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer 2011; 117: 4390-4395.
42. Lang BH, Chai YJ, Cowling BJ, Min HS, Lee KE, Youn YK,. Is BRAFV600E mutation a marker for central nodal metastasis in small papillary thyroid carcinoma? Endocr Relat Cancer 2014; 21: 285-295.
43. Chung KW, Yang SK, Lee GK, et al., Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf) 2006; 65: 660-666.
44. Patron V, Bedfert C, Le Clech G, Aubry K, Jegoux F,. Pattern of lateral neck metastases in N0 papillary thyroid carcinoma. BMC Cancer 2011; 11: 8.
45. Mercante G, Frasoldati A, Pedroni C, et al., Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 2009; 19: 707-716.
46. Kim KH, Suh KS, Kang DW, Kang DY,. Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis. Pathol Int 2005; 55: 540-545.
47. Sargent R, LiVolsi V, Murphy J, Mantha G, Hunt JL,. BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis. Endocr Pathol 2006; 17: 235-241.
48. Caleo A, Vigliar E, Vitale M, et al., Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients. BMC Surg 2013; 13 Suppl 2: S41.
49. Guerra A, Di Stasi V, Zeppa P, Faggiano A, Marotta V, Vitale M,. BRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay. Endocrine 2014; 45: 249-255.
50. Lee ST, Kim SW, Ki CS, et al., Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area. J Clin Endocrinol Metab 2012; 97: 2299-2306.